| abstract |
FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely to oncology and may be used for the purpose of the integrated treatment of the patients with oncological diseases. For this purpose, a drug preparation of cytostatic group and a drug preparation of fragmented double-stranded DNA with fragments having a biologically active size and making a complete genome of a physiologically and genetically healthy donor in the form of tablets is administered into the patient's body. A tablet containing 5 mg of the active ingredient is used according to the scheme in 30 min and 2, 3 and 5 days after the administration of cyclophosphan in the amount of one tablet in the first 30 minutes after the administration of cyclophosphan. Further on these days, one tablet is taken every 2-3 hours a day while awake, but no more than 30 mg of the active ingredient a day. n EFFECT: use of the given method enables achieving an increase of mature dendritic cell count in the body that allows achieving the maximum development of the retrogressive effect on the tumour. n 1 ex, 6 dwg |